New Opportunity: OncoSec Medical Inc. (NASDAQ: ONCS)
We are back in action as the Fall Trading Season kicks off. And we are looking back to the Nasdaq – in the biopharma space.
Our newest alert is ONCS: a deep value play with a strong pipeline of assets, including an orphan drug status play and a recent huge HR steal from the top-tier segment.
The chart is very interesting as the stock tests key long-term support at the $1/share level after registering strong oversold/bounce-potential readings on the key oscillators. We are also looking at a tiny float in play.
All in all, it adds up to some huge potential right now!
Company: OncoSec Medical Inc.
Latest News: http://finance.yahoo.com/q/h?s=ONCS+Headlines
Company Website: http://www.oncosec.com